Cargando…
Mapping MKP-3/FOXO1 Interaction and Evaluating the Effect on Gluconeogenesis
BACKGROUND: MAP kinase phosphatase 3 (MKP-3) is known to attenuate the ERK signaling pathway. It has been recently demonstrated that MKP-3 is also a player in promoting hepatic glucose output in obese state by interacting and activating FOXO1. Reduction of hepatic MKP-3 expression is sufficient to r...
Autores principales: | Jiao, Ping, Feng, Bin, Xu, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405053/ https://www.ncbi.nlm.nih.gov/pubmed/22848439 http://dx.doi.org/10.1371/journal.pone.0041168 |
Ejemplares similares
-
Hepatocentric Leptin Signaling Modulates Gluconeogenesis via MKP-3
por: Gamarra, Jennifer R., et al.
Publicado: (2022) -
Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction
por: Liu, Qun, et al.
Publicado: (2017) -
Mitogen-Activated Protein Kinase Phosphatase 3 (MKP-3)–Deficient Mice Are Resistant to Diet-Induced Obesity
por: Feng, Bin, et al.
Publicado: (2014) -
FAM3B (PANDER) functions as a co‐activator of FOXO1 to promote gluconeogenesis in hepatocytes
por: Chi, Yujing, et al.
Publicado: (2018) -
FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
por: Kim, Dae Hyun, et al.
Publicado: (2011)